A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour

Background. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy which is characterised by abnormal growth of the trophoblasts at the placental site. It is categorised into benign and malignant forms, which include hydatidiform moles (HMs) and gestational trophoblastic neoplas...

Full description

Bibliographic Details
Main Authors: Wan Yu Luk, Michael Friedlander
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2013/492754
id doaj-638b7ccefee7470da8f7f01ae1f32c1f
record_format Article
spelling doaj-638b7ccefee7470da8f7f01ae1f32c1f2020-11-25T01:28:25ZengHindawi LimitedCase Reports in Obstetrics and Gynecology2090-66842090-66922013-01-01201310.1155/2013/492754492754A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic TumourWan Yu Luk0Michael Friedlander1Royal Hospital for Women, Barker Street, Randwick, NSW 2031, AustraliaGyneacological Cancer Centre, Royal Hospital for Women, Randwick, NSW 2031, AustraliaBackground. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy which is characterised by abnormal growth of the trophoblasts at the placental site. It is categorised into benign and malignant forms, which include hydatidiform moles (HMs) and gestational trophoblastic neoplasia (GTN), respectively. A mixed choriocarcinoma (CC) and epithelioid trophoblastic tumour (ETT) is an extremely rare subgroup of GTN, which is a highly curable but aggressive form of malignancy. Case. We report a case of mixed CC and ETT in a 41-year-old patient who presented with a 2-year history of menorrhagia and fibroid uterus in the absence of previous history of molar pregnancy. She had a 12-year interval between the antecedent pregnancy and presentation. She was treated with intensive regimen of adjuvant chemotherapy, etoposide, methotrexate, and actinomycin-D with etoposide and cisplatin (EMA-EP). She has remained disease free for more than 5 years. Conclusion. This case highlights the importance of considering GTN as one of the differential diagnoses value of β-HCG in patients presented with menorrhagia and growing fibroids.http://dx.doi.org/10.1155/2013/492754
collection DOAJ
language English
format Article
sources DOAJ
author Wan Yu Luk
Michael Friedlander
spellingShingle Wan Yu Luk
Michael Friedlander
A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
Case Reports in Obstetrics and Gynecology
author_facet Wan Yu Luk
Michael Friedlander
author_sort Wan Yu Luk
title A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
title_short A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
title_full A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
title_fullStr A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
title_full_unstemmed A Fibroid or Cancer? A Rare Case of Mixed Choriocarcinoma and Epithelioid Trophoblastic Tumour
title_sort fibroid or cancer? a rare case of mixed choriocarcinoma and epithelioid trophoblastic tumour
publisher Hindawi Limited
series Case Reports in Obstetrics and Gynecology
issn 2090-6684
2090-6692
publishDate 2013-01-01
description Background. Gestational trophoblastic disease (GTD) is a rare complication of pregnancy which is characterised by abnormal growth of the trophoblasts at the placental site. It is categorised into benign and malignant forms, which include hydatidiform moles (HMs) and gestational trophoblastic neoplasia (GTN), respectively. A mixed choriocarcinoma (CC) and epithelioid trophoblastic tumour (ETT) is an extremely rare subgroup of GTN, which is a highly curable but aggressive form of malignancy. Case. We report a case of mixed CC and ETT in a 41-year-old patient who presented with a 2-year history of menorrhagia and fibroid uterus in the absence of previous history of molar pregnancy. She had a 12-year interval between the antecedent pregnancy and presentation. She was treated with intensive regimen of adjuvant chemotherapy, etoposide, methotrexate, and actinomycin-D with etoposide and cisplatin (EMA-EP). She has remained disease free for more than 5 years. Conclusion. This case highlights the importance of considering GTN as one of the differential diagnoses value of β-HCG in patients presented with menorrhagia and growing fibroids.
url http://dx.doi.org/10.1155/2013/492754
work_keys_str_mv AT wanyuluk afibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour
AT michaelfriedlander afibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour
AT wanyuluk fibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour
AT michaelfriedlander fibroidorcancerararecaseofmixedchoriocarcinomaandepithelioidtrophoblastictumour
_version_ 1725101831318667264